Researcher in converting insights and data into research materials through MS Excel, MS PowerPoint and other similar tools... applications, particularly Excel and PowerPoint, and the ability to translate data from Excel files into clear, concise...
NBCC's shares hit a new high after the company announced a potential bonus share issue. The Board of Directors will discuss the proposal on August 31, 2024. The company's shares have soared 151% this year, driven by significant contract wins and order acquisitions. Continue Reading »
Remedium Lifecare said its Board of Directors will consider issuing of Foreign Currency Convertible Bonds (FCCBs) and acquisition of Airowater Global Trading LLC, UAE, on September 3. Continue Reading »
Orient Technologies made a strong market debut, listing at ₹288 on NSE, a 40% premium over its issue price of ₹206. The stock surged to ₹302 apiece, marking a 47% gain for retail investors. Continue Reading »
Rapid Multimodal Logistics IPO allotment is set for today, August 28. The IPO received 350 times subscription and shares will be listed on BSE SME on August 30. Continue Reading »
Raj Rayon Industries transitioned from a penny stock to a success story, delivering impressive returns despite short-term volatility. From ₹5 in 2019 to ₹24 now, it saw a 380% rise. However, recent performance showed a 47% loss over the past year but a 28% gain in 2024 year-to-date. Continue Reading »
Riding the wave of AI innovation, E2E Networks' stock soared 280% year-to-date. The company is poised to benefit from India's under-penetrated data centre market, though it remains cautious about expansion plans Continue Reading »
Foreign promoters increased their ownership in NSE-listed companies by 28 bps QoQ, bringing their stake to 8.3%. In contrast, private Indian promoters saw their ownership decline by 33 bps QoQ, reaching an 18-quarter low of 32.4% in the June quarter. Continue Reading »
Indegene's stock, which debuted at ₹659.70, has dropped nearly 15% to ₹562.25 but remains 24% higher than its IPO price of ₹452. JPMorgan initiated coverage with a 'neutral' call and a target price of ₹570 for September 2025. Continue Reading »